Show simple item record

dc.contributor.advisorRay, Michael
dc.contributor.authorZagari, Ciarra
dc.date.accessioned2021-09-08T14:16:25Z
dc.date.available2021-09-08T14:16:25Z
dc.date.issued5/4/2017
dc.identifier.urihttp://hdl.handle.net/20.500.12648/6651
dc.description.abstractThis paper explores the cost-effectiveness of New York State-approved syringe exchange programs (SEPs), and provides an estimate of the annual savings in healthcare costs due to these programs. The research utilizes the simplified circulation model that estimated cost savings in Laufer’s (2001) study, however with the most recent data. The cost-effectiveness analysis used data provided by seventeen SEPs, as well as published data for the most recent 12-month period available, and treatment costs from the literature. An estimated 1,608 human immunodeficiency virus (HIV) cases are averted annually in the injection drug user (IDU) population, which translates to about $51,754,152 in treatment cost savings each year due to syringe exchange programs in New York. This research further demonstrates the cost-effectiveness of syringe exchange as prevention strategy.
dc.subjectSenior Honors Thesis
dc.subjectInjection Drug User
dc.subjectSyringe Exchange
dc.subjectHIV Cost-Effectiveness
dc.titleReducing Healthcare Costs in New York with Syringe Exchange Program Implementation
dc.typethesis
refterms.dateFOA2021-09-08T14:16:25Z
dc.description.institutionSUNY Brockport
dc.description.departmentPublic Health and Health Education
dc.source.statuspublished
dc.description.publicationtitleSenior Honors Theses
dc.contributor.organizationThe College at Brockport
dc.languate.isoen_US


Files in this item

Thumbnail
Name:
honors/173/fulltext (1).pdf
Size:
536.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record